HCA Healthcare Inc

HCA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$548.00LwlggqWzndzqcf

HCA Earnings: Increasing Fair Value Estimate on Strong Utilization Trends and Higher 2024 Outlook

Narrow-moat HCA Healthcare turned in better-than-anticipated second-quarter results on improving medical utilization trends, and the firm raised its guidance for 2024 above our previous expectations. After accounting for these strong trends and cash flows generated since our last valuation update, we are raising our fair value estimate by 11% to $316 per share from $285. We continue to view HCA shares as mildly overvalued, though, after investors have bid up this healthcare services bellwether in a rising medical utilization environment.

Sponsor Center